MicroRNA-4472 Promotes Tumor Proliferation and Aggressiveness in Breast Cancer by Targeting RGMA and Inducing EMT

Area of Science:

• Oncology
• Molecular Biology
• Gene Regulation

Background:

• Breast cancer is a leading cause of cancer death in women globally.
• MicroRNAs (miRNAs) play a role in breast cancer gene regulation, chemoresistance, growth, and metastasis.
• miR-4472 was found to be upregulated in breast cancer, associated with larger tumors and chemoresistance, but its function was unknown.

Purpose of the Study:

• To investigate the biological function and molecular mechanisms of miR-4472 in breast cancer progression.
• To identify the target genes of miR-4472 and elucidate its role in epithelial-to-mesenchymal transition (EMT).
• To explore the potential of the miR-4472/RGMA axis as a therapeutic target.

Main Methods:

• Real-time quantitative polymerase chain reaction (RT-qPCR) to measure miR-4472 expression.
• Transwell, cell proliferation, and flow cytometry assays to assess biological functions.
• Bioinformatics, dual-luciferase reporter assays, and Western blot to identify target genes and EMT markers.

Main Results:

• miR-4472 was significantly upregulated in metastatic breast cancer tissues, correlating with tumor size and stage.
• miR-4472 promoted breast cancer cell metastasis and growth.
• Repulsive guidance molecule A (RGMA) was identified as a direct miR-4472 target, acting as a metastasis suppressor. miR-4472 downregulated RGMA, suppressed E-cadherin, and induced vimentin, β-catenin, and Slug, promoting EMT.

Conclusions:

• miR-4472 drives breast cancer progression by regulating RGMA and inducing EMT.
• The miR-4472/RGMA pathway represents a promising therapeutic target for breast cancer.